BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34199734)

  • 1. Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study.
    Saussez S; Vaira LA; Chiesa-Estomba CM; Bon SL; Horoi M; Deiana G; Petrocelli M; Boelpaep P; Salzano G; Khalife M; Hans S; De Riu G; Hopkins C; Lechien JR
    Pathogens; 2021 Jun; 10(6):. PubMed ID: 34199734
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: a prospective study.
    Lechien JR; Vaira LA; Saussez S
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1255-1263. PubMed ID: 36153785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients.
    Lechien JR; Chiesa-Estomba CM; Vaira LA; De Riu G; Cammaroto G; Chekkoury-Idrissi Y; Circiu M; Distinguin L; Journe F; de Terwangne C; Machayekhi S; Barillari MR; Calvo-Henriquez C; Hans S; Saussez S
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):2851-2859. PubMed ID: 33452919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
    Le Bon SD; Konopnicki D; Pisarski N; Prunier L; Lechien JR; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3113-3117. PubMed ID: 33423106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.
    Cantone E; D'Ascanio L; De Luca P; Roccamatisi D; La La Mantia I; Brenner MJ; Di Stadio A
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3671-3678. PubMed ID: 38492007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter real-life study to determine the efficacy of corticosteroids and olfactory training in improving persistent COVID-19-related olfactory dysfunction.
    Pendolino AL; Ottaviano G; Nijim J; Scarpa B; De Lucia G; Berro C; Nicolai P; Andrews PJ
    Laryngoscope Investig Otolaryngol; 2022 Dec; 8(1):46-54. PubMed ID: 36718474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients.
    Vaira LA; Lechien JR; Khalife M; Petrocelli M; Hans S; Distinguin L; Salzano G; Cucurullo M; Doneddu P; Salzano FA; Biglioli F; Journe F; Piana AF; De Riu G; Saussez S
    Pathogens; 2021 Jan; 10(1):. PubMed ID: 33445604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.
    Lechien JR; Le Bon SD; Saussez S
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2351-2358. PubMed ID: 36520209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction.
    Saussez S; Sharma S; Thiriard A; Olislagers V; Vu Duc I; Le Bon SD; Khalife M; Hans S; De Riu G; Hopkins C; Lechien JR; Vaira LA; Marchant A
    Eur J Neurol; 2021 Nov; 28(11):3702-3711. PubMed ID: 34157187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients.
    Lechien JR; Chiesa-Estomba CM; Beckers E; Mustin V; Ducarme M; Journe F; Marchant A; Jouffe L; Barillari MR; Cammaroto G; Circiu MP; Hans S; Saussez S
    J Intern Med; 2021 Aug; 290(2):451-461. PubMed ID: 33403772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of prevalence and evolution of COVID-19 olfactory disorders in patients infected by D614 (wild) and B.1.1.7. Alpha variant: a brief report.
    Lechien JR; Wajsblat S; Horoi M; Boscolo-Rizzo P; Le Bon SD; Vaira LA; Saussez S
    Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3461-3467. PubMed ID: 36943439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory Cleft Measurements and COVID-19-Related Anosmia.
    Altundag A; Yıldırım D; Tekcan Sanli DE; Cayonu M; Kandemirli SG; Sanli AN; Arici Duz O; Saatci O
    Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1337-1344. PubMed ID: 33045908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Olfactory MRI, DTI and fMRI Study of COVID-19 Related Anosmia and Post Viral Olfactory Dysfunction.
    Yildirim D; Kandemirli SG; Tekcan Sanli DE; Akinci O; Altundag A
    Acad Radiol; 2022 Jan; 29(1):31-41. PubMed ID: 34810059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory training in long COVID-19 patients with lasting symptoms including olfactory dysfunction.
    Fjaeldstad AW; Ovesen T; Stankevice D; Ovesen T
    Dan Med J; 2023 Feb; 70(3):. PubMed ID: 36896723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pilot Study of Short-Course Oral Vitamin A and Aerosolised Diffuser Olfactory Training for the Treatment of Smell Loss in Long COVID.
    Chung TW; Zhang H; Wong FK; Sridhar S; Lee TM; Leung GK; Chan KH; Lau KK; Tam AR; Ho DT; Cheng VC; Yuen KY; Hung IF; Mak HK
    Brain Sci; 2023 Jun; 13(7):. PubMed ID: 37508945
    [No Abstract]   [Full Text] [Related]  

  • 16. Olfactory dysfunction and training in children with COVID-19 infection: A prospective study Post-COVID pediatric olfactory training.
    Chan KH; Thomas BJ; Gilbert DD; Tong S; Teynor NJ; Friedman NR; Herrmann BW; Gitomer SA
    Int J Pediatr Otorhinolaryngol; 2024 Jan; 176():111799. PubMed ID: 38081110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial.
    Di Stadio A; Cantone E; De Luca P; Di Nola C; Massimilla EA; Motta G; La Mantia I; Motta G
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.
    Lechien JR; Cabaraux P; Chiesa-Estomba CM; Khalife M; Hans S; Calvo-Henriquez C; Martiny D; Journe F; Sowerby L; Saussez S
    Head Neck; 2020 Jul; 42(7):1583-1590. PubMed ID: 32437033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of olfactory dysfunction and parosmia in mild COVID-19 cases.
    Monk AS; Bacon DR; Onuorah P; Murr A; Wiesen CA; Oakes J; Thorp BD; Ebert CS; Wohl D; Senior BA; Kimple AJ
    Rhinol Online; 2022; 5():168-172. PubMed ID: 37008801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sniffin'Sticks: a new olfactory test battery.
    Wolfensberger M; Schnieper I; Welge-Lüssen A
    Acta Otolaryngol; 2000 Mar; 120(2):303-6. PubMed ID: 11603794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.